Минздрав прокомментировал применение противомалярийного препарата у пациентов с COVID-19
Министерство не планирует отказываться от рекомендации применения противомалярийного препарата гидроксихлорохин при терапии новой коронавирусной инфекции. Сообщение об этом опубликовано 28 мая на сайте Минздрава.
Таким образом Минздрав прокомментировал решение Всемирной организации здравоохранения отказаться от дальнейших исследований применения гидроксихлорохина у пациентов с COVID-19 из‑за кардиотоксичности, которая способна приводить к жизнеугрожающим нарушениям ритма сердца у госпитализированных пациентов.
Министерство отмечает, что включение гидроксихлорохина во временный перечень рекомендованных препаратов для лечения коронавирусной инфекции основано на опыте использования этого ЛС в мировой практике, а также на исследованиях, подтвердивших эффективность препарата в отношении инфекционного агента in vitro.
Минздрав обращает внимание, что в последней версии временных методических рекомендаций указана необходимость контроля сердечного ритма у пациентов, получающих гидроксихлорохин, а также запрет на его прием больными с высоким риском развития аритмий. Кроме этого, поскольку препарат не имеет зарегистрированных показаний для лечения коронавируса, все пациенты дают свое информированное согласие на его применение.
По результатам мониторинга безопасности гидроксихлорохина в период пандемии COVID-19 в России не выявлено летальных исходов, связанных с нарушением ритма у пациентов на фоне приема этого препарата.
Минздрав также заявил, что завершает подготовку седьмой версии Временных методических рекомендаций по диагностике, профилактике и лечению COVID-19. В них будут включены дополнительные критерии для оценки врачом пользы и риска использования гидроксихлорохина, а также меры по мониторингу и профилактике аритмий в период лечения.
29 мая 2020
Фото: depositphotos.com
Выпуск: №196, май 20202876 просмотров
Array ( [0] => Array ( [ID] => 16466 [~ID] => 16466 [NAME] => apteka.ru/search/?q=%D1%81%D1%82%D0%B5%D0%BB%D0%BB%D0%B0%D0%BD%D0%B8%D0%BD&order=products%2Cmaterials&vendor= [~NAME] => apteka.ru/search/?q=%D1%81%D1%82%D0%B5%D0%BB%D0%BB%D0%B0%D0%BD%D0%B8%D0%BD&order=products%2Cmaterials&vendor= [DATE_ACTIVE_FROM] => 01.09.2019 11:17:00 [~DATE_ACTIVE_FROM] => 01.09.2019 11:17:00 [IBLOCK_ID] => 12 [~IBLOCK_ID] => 12 [PREVIEW_PICTURE] => 8171 [~PREVIEW_PICTURE] => 8171 ) [PROPERTIES] => Array ( [SWF] => Array ( [ID] => 99 [TIMESTAMP_X] => 2018-08-19 19:34:17 [IBLOCK_ID] => 12 [NAME] => Ссылка во флеше (link1) [ACTIVE] => Y [SORT] => 500 [CODE] => SWF [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 50 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Ссылка во флеше (link1) [~DEFAULT_VALUE] => ) [LINK] => Array ( [ID] => 100 [TIMESTAMP_X] => 2018-08-19 19:34:17 [IBLOCK_ID] => 12 [NAME] => Ссылка (без протокола) [ACTIVE] => Y [SORT] => 500 [CODE] => LINK [DEFAULT_VALUE] => [PROPERTY_TYPE] => S [ROW_COUNT] => 1 [COL_COUNT] => 50 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => 320465417 [VALUE] => apteka.ru/search/?q=%D0%B1%D0%B5%D1%80%D0%B5%D1%88&order=products%2Cmaterials&vendor=0 [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => apteka.ru/search/?q=%D0%B1%D0%B5%D1%80%D0%B5%D1%88&order=products%2Cmaterials&vendor=0 [~DESCRIPTION] => [~NAME] => Ссылка (без протокола) [~DEFAULT_VALUE] => ) [WEBINARS] => Array ( [ID] => 102 [TIMESTAMP_X] => 2020-11-05 08:23:57 [IBLOCK_ID] => 12 [NAME] => Вебинары [ACTIVE] => Y [SORT] => 500 [CODE] => WEBINARS [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 5 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => Y [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => EList [USER_TYPE_SETTINGS] => Array ( [size] => 20 [width] => 0 [group] => Y [multiple] => Y ) [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Вебинары [~DEFAULT_VALUE] => ) [TYPES] => Array ( [ID] => 103 [TIMESTAMP_X] => 2018-08-20 03:08:52 [IBLOCK_ID] => 12 [NAME] => Где показывать [ACTIVE] => Y [SORT] => 500 [CODE] => TYPES [DEFAULT_VALUE] => [PROPERTY_TYPE] => L [ROW_COUNT] => 20 [COL_COUNT] => 30 [LIST_TYPE] => C [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => Y [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 320482201 ) [VALUE] => Array ( [0] => Страница статьи (273px) ) [DESCRIPTION] => Array ( [0] => ) [VALUE_ENUM] => Array ( [0] => Страница статьи (273px) ) [VALUE_XML_ID] => Array ( [0] => ade3837e8e0b9a67adab1fec2bc57639 ) [VALUE_SORT] => Array ( [0] => 500 ) [VALUE_ENUM_ID] => Array ( [0] => 458 ) [~VALUE] => Array ( [0] => Страница статьи (273px) ) [~DESCRIPTION] => Array ( [0] => ) [~NAME] => Где показывать [~DEFAULT_VALUE] => ) [RUBRICS] => Array ( [ID] => 104 [TIMESTAMP_X] => 2018-08-20 03:09:12 [IBLOCK_ID] => 12 [NAME] => Рубрики [ACTIVE] => Y [SORT] => 500 [CODE] => RUBRICS [DEFAULT_VALUE] => [PROPERTY_TYPE] => G [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 20 [TMP_ID] => [LINK_IBLOCK_ID] => 2 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => Y [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Рубрики [~DEFAULT_VALUE] => ) [VIEWS] => Array ( [ID] => 105 [TIMESTAMP_X] => 2018-08-19 23:38:24 [IBLOCK_ID] => 12 [NAME] => Показы [ACTIVE] => Y [SORT] => 500 [CODE] => VIEWS [DEFAULT_VALUE] => [PROPERTY_TYPE] => N [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Показы [~DEFAULT_VALUE] => ) [CLICKS] => Array ( [ID] => 106 [TIMESTAMP_X] => 2018-08-19 23:38:24 [IBLOCK_ID] => 12 [NAME] => Клики [ACTIVE] => Y [SORT] => 500 [CODE] => CLICKS [DEFAULT_VALUE] => [PROPERTY_TYPE] => N [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 0 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => [USER_TYPE_SETTINGS] => [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Клики [~DEFAULT_VALUE] => ) [ARTICLE] => Array ( [ID] => 116 [TIMESTAMP_X] => 2019-05-17 13:18:54 [IBLOCK_ID] => 12 [NAME] => Статьи [ACTIVE] => Y [SORT] => 500 [CODE] => ARTICLE [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => Y [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 2 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => EList [USER_TYPE_SETTINGS] => Array ( [size] => 20 [width] => 0 [group] => N [multiple] => Y ) [HINT] => [PROPERTY_VALUE_ID] => Array ( [0] => 320482202 ) [VALUE] => Array ( [0] => 32724 ) [DESCRIPTION] => Array ( [0] => ) [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => Array ( [0] => 32724 ) [~DESCRIPTION] => Array ( [0] => ) [~NAME] => Статьи [~DEFAULT_VALUE] => ) [CRIB] => Array ( [ID] => 117 [TIMESTAMP_X] => 2019-05-30 07:53:16 [IBLOCK_ID] => 12 [NAME] => Шпаргалки [ACTIVE] => Y [SORT] => 500 [CODE] => CRIB [DEFAULT_VALUE] => [PROPERTY_TYPE] => E [ROW_COUNT] => 1 [COL_COUNT] => 30 [LIST_TYPE] => L [MULTIPLE] => N [XML_ID] => [FILE_TYPE] => [MULTIPLE_CNT] => 5 [TMP_ID] => [LINK_IBLOCK_ID] => 3 [WITH_DESCRIPTION] => N [SEARCHABLE] => N [FILTRABLE] => N [IS_REQUIRED] => N [VERSION] => 1 [USER_TYPE] => EList [USER_TYPE_SETTINGS] => Array ( [size] => 20 [width] => 0 [group] => N [multiple] => N ) [HINT] => [PROPERTY_VALUE_ID] => [VALUE] => [DESCRIPTION] => [VALUE_ENUM] => [VALUE_XML_ID] => [VALUE_SORT] => [~VALUE] => [~DESCRIPTION] => [~NAME] => Шпаргалки [~DEFAULT_VALUE] => ) ) [1] => Array ( [ID] => 15705 [~ID] => 15705 [NAME] => Стелланин апрель [~NAME] => Стелланин апрель [DATE_ACTIVE_FROM] => 01.04.2019 13:37:00 [~DATE_ACTIVE_FROM] => 01.04.2019 13:37:00 [IBLOCK_ID] => 12 [~IBLOCK_ID] => 12 [PREVIEW_PICTURE] => 7449 [~PREVIEW_PICTURE] => 7449 ) [2] => Array ( [ID] => 32741 [~ID] => 32741 [NAME] => Береш Май Обзор писем РЗН [~NAME] => Береш Май Обзор писем РЗН [DATE_ACTIVE_FROM] => 28.05.2020 08:53:00 [~DATE_ACTIVE_FROM] => 28.05.2020 08:53:00 [IBLOCK_ID] => 12 [~IBLOCK_ID] => 12 [PREVIEW_PICTURE] => 10191 [~PREVIEW_PICTURE] => 10191 ) )
2876 просмотров
Поделиться ссылкой с друзьями ВКонтакте Одноклассники
Нашли ошибку? Выделите текст и нажмите Ctrl+Enter.
зарегистрированным пользователям